It's been 25 years since we last improved antibiotics, but bacteria keep evolving
Despite Growing Threat Of Deadly Superbugs, New Antibiotic Research Screeches To A Halt | ThinkProgress
In modern times, antibiotics are largely taken for granted. But this complacent public attitude ignores the reality that such treatments require years — if not decades — to develop. Antibiotics also have limited shelf lives, since bacteria evolve and adapt to them. That wouldn’t be a problem if it weren’t for the fact that there have been zero major new antibiotics developed in the last 25 years, leaving the global community susceptible to the rise of drug-resistant bacteria:
While a new infectious disease has been discovered nearly every year over the past 30 years, there have been no new antibiotics since 1987, leaving our armory nearly empty as diseases become resistant to existing drugs.
“The barriers to approval of nine additional antibiotics by 2020 seem insurmountable,” said Henry Chambers, chair of IDSA’s Antimicrobial Resistance Committee (ARC).
“We’re losing ground because we are not developing new drugs in pace with superbugs’ ability to develop resistance to them. We’re on the precipice of returning to the dark days before antibiotics enabled safer surgery, chemotherapy and the care of premature infants. We’re all at risk,” said Helen Boucher, from IDSA.